
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, CIO, SNV on Behalf of Shareholders
iTeos Therapeutics, Inc. (NASDAQ: ITOS)'s sale to Concentra Biosciences, LLC. Under the terms of the proposed transaction, Concentra will acquire iTeos for $10.047 in cash per share, plus one non-transferable contingent value right, representing the right to receive: (i) 100% of the closing net cash of iTeos in excess of $475 million; and (ii) 80% of any net proceeds received from any disposition of certain of iTeos' product candidates that occurs within six months following the closing. If you are an iTeos shareholder, click here to learn more about your rights and options.
City Office REIT, Inc. (NYSE: CIO)'s sale to MCME Carell Holdings, LP and MCME Carell Holdings, LLC for $7.00 per share in cash. If you are a City Office shareholder, click here to learn more about your legal rights and options.
Synovus Financial Corp. (NYSE: SNV)'s merger with Pinnacle Financial Partners. Under the terms of the proposed transaction, the shares of Synovus and Pinnacle shareholders will be converted into shares of a new Pinnacle parent company based on a fixed exchange ratio of 0.5237 Synovus shares per Pinnacle share. Upon closing of the proposed transaction, Synovus shareholders will own approximately 48.5% of the combined company. If you are a Synovus shareholder, click here to learn more about your legal rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:Halper Sadeh LLCDaniel Sadeh, Esq.Zachary Halper, Esq.One World Trade Center85th FloorNew York, NY 10007(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
American Airlines Group Inc. (AAL) Reports Second-Quarter Results; Exceeds Expectations
American Airlines Group Inc. (NASDAQ:AAL) is included in our list of the . Pixabay/Public Domain On July 24, 2025, American Airlines Group Inc. (NASDAQ:AAL) reported Q2 2025 earnings. The stronger-than-expected earnings were marked by adjusted EPS of $0.95, exceeding the consensus estimate of $0.79. Furthermore, resilient premium demand and strong international performance, particularly in transatlantic routes, helped the company post revenue of $14.4 billion. However, domestic unit revenue dropped 6% YoY due to softness in domestic leisure. Meanwhile, American Airlines Group Inc. (NASDAQ:AAL) maintained an operating margin of 8% and generated $791 million in free cash flow during the quarter. The company's financial health further improved with debt repayments, taking its net debt to $29 billion, the lowest since 2015. For Q3, American Airlines Group Inc. (NASDAQ:AAL) has projected EPS to range between a $0.10 and $0.60 loss. The company does consider July as the trough, but anticipates sequential improvement in revenue. For the full year, it expects its EPS to range from a $0.20 loss to a $0.80 profit. Looking beyond 2025, American Airlines Group Inc. (NASDAQ:AAL) expects a full recovery of indirect channel share by the end of this year which would boost 2026 revenue. On the analyst front, BofA, on July 25, 2025, increased its price target on American Airlines Group Inc. (NASDAQ:AAL) from $12 to $13, maintaining a 'Neutral' rating. The analyst cited Q3 guidance that fell below expectations. American Airlines Group Inc. (NASDAQ:AAL), a network air carrier, provides scheduled air transportation services for passengers and cargo. It is included in our list of cheap travel stocks. While we acknowledge the potential of AAL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Most Undervalued Cloud Stocks Under $10 According to Hedge Funds and 11 Best Mineral Stocks to Buy According to Hedge Funds. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 minutes ago
- Yahoo
TD Cowen and BofA Bullish on Carnival Corporation & plc (CCL) Amid Strong Travel Momentum
Carnival Corporation & plc (NYSE:CCL), considered a cheaply priced stock and a top pick among analysts, is included in our list of the . A bustling airport terminal with travelers heading to their dream destination. As the travel industry's momentum is on an upward trajectory, Carnival Corporation & plc (NYSE:CCL) is attracting the attention of Wall Street. On July 22, 2025, citing the company's disciplined capacity growth, TD Cowen gave Carnival Corporation & plc (NYSE:CCL) a 'Buy' rating with a $36 price target. Instead of scaling up, the company is focusing on yield optimization with the help of its proprietary YODA system. The system resulted in an industry-leading 7% yield growth in the first half of 2025 with a strong gross margin of 54.7%. The analyst expects a five-year CAGR of 19% in net income and 21% in EPS due to this focus on margins and declining interest expenses. Furthermore, on July 23, 2025, BofA increased its price target on Carnival Corporation & plc (NYSE:CCL) from $31 to $38. The analyst, too, cited the growing momentum of cruise equities, along with strong earnings expectations. Carnival Corporation & plc (NYSE:CCL), a leisure travel company, offers cruise vacations with brands like Carnival Cruise Line, Princess Cruises, and Holland America Line. It is included in our list of cheap travel stocks. While we acknowledge the potential of CCL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 14 Cheap Transportation Stocks to Buy According to Analysts and 10 Cheap Lithium Stocks to Buy According to Hedge Funds. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 minutes ago
- Yahoo
Indivior PLC (INDV) Reinvents Leadership, Moves Listing to Nasdaq
We recently compiled a list of Indivior PLC stands seventh on our list among the best mid cap stocks according to billionaires. Indivior PLC (NASDAQ:INDV) is a pharmaceutical company focused on opioid addiction treatment, particularly through its flagship product SUBLOCADE, a monthly buprenorphine injection. The company has demonstrated strong growth and resilience, recently reaching a 52-week stock high. In 2025, Indivior PLC (NASDAQ:INDV) underwent a strategic leadership overhaul to strengthen its market position in the U.S., the primary arena for its operations. Joe Ciaffoni took over as CEO, bringing a fresh vision to the company, while Patrick Barry joined as Chief Commercial Officer to drive commercial expansion, especially around SUBLOCADE. Tony Kingsley also joined the board to enhance governance. These changes reflect a focused effort to boost performance and align leadership with U.S. market priorities. In line with this strategy, the business announced its plan to shift its primary listing from the London Stock Exchange to Nasdaq, aiming for greater visibility and investor engagement in the American market. Photo by Matteo Badini on Unsplash On the clinical front, Indivior PLC (NASDAQ:INDV) presented new findings at the 2025 CPDD meeting showing that higher buprenorphine exposure may improve treatment outcomes in patients with high fentanyl use, a critical step given the ongoing fentanyl crisis. The FDA also approved updated labeling for SUBLOCADE, further expanding its clinical utility. While we acknowledge the potential of INDV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.